The biobank automation systems market size has grown strongly in recent years. It will grow from $2.03 billion in 2025 to $2.22 billion in 2026 at a compound annual growth rate (CAGR) of 9.7%. The growth in the historic period can be attributed to growth in biomedical research, increasing biobank sample volumes, need for error reduction, expansion of genomics studies, laboratory automation adoption.
The biobank automation systems market size is expected to see strong growth in the next few years. It will grow to $3.19 billion in 2030 at a compound annual growth rate (CAGR) of 9.4%. The growth in the forecast period can be attributed to precision medicine expansion, ai-driven sample management, global biobank collaborations, regulatory compliance requirements, demand for scalable storage solutions. Major trends in the forecast period include automated sample storage, robotic sample handling, high-throughput biobanking, digital sample traceability, integrated biobank software systems.
The rising prevalence of chronic diseases is expected to propel the growth of the biobank automation systems market moving forward. Chronic diseases, such as diabetes, cardiovascular diseases, cancer, and chronic respiratory disorders, are long-lasting conditions that generally progress slowly and require ongoing medical management. The increasing incidence of chronic diseases is largely attributed to population aging, with a growing number of people living into older age groups where conditions like cardiovascular disease, diabetes, and cancer are more common. Biobank automation systems help manage the growing burden of chronic diseases by enabling the reliable, large-scale storage and rapid retrieval of patient biospecimens for research, biomarker discovery, and the development of targeted therapies. For example, in February 2024, the World Health Organization (WHO) projected that global cancer incidence would exceed 35 million new cases by 2050, a 77% increase over the 20 million new cases reported in 2022. As a result, the rising prevalence of chronic diseases is driving the biobank automation systems market.
Leading companies in the biobank automation systems market are focusing on advanced innovations, such as eco-friendly cooling systems, to improve energy efficiency, reduce carbon footprints, and optimize large-scale sample storage. Eco-friendly cooling systems utilize advanced refrigeration technologies that use natural air or non-ozone-depleting refrigerants to minimize energy consumption, lower environmental impact, and support sustainable ultracold storage operations. For example, in February 2024, Azenta, Inc., a US-based life sciences company, launched the BioArc Ultra, a groundbreaking automated solution for high-density and eco-friendly ultracold sample management. BioArc Ultra enables automated, high-density ultracold sample storage and retrieval, helping biobanks maximize freezer capacity while maintaining sample integrity. The system also supports more sustainable biobanking operations through its energy-efficient design and eco-friendly refrigerants, reducing the environmental footprint of large-scale sample management. It is designed to streamline complex biorepository workflows, minimize manual handling risks, and offer secure, traceable management of critical biological samples for research and clinical applications.
In February 2023, Azenta Inc., a US-based life sciences company specializing in automated sample management and cold-chain solutions, acquired Ziath Ltd for an undisclosed amount. Through this acquisition, Azenta aims to strengthen its end-to-end sample lifecycle solutions by integrating advanced two-dimensional barcode scanning technologies that enhance accuracy, traceability, and high-throughput automation across sample registration, storage, and processing workflows for global life sciences clients. Ziath Ltd is a UK-based company specializing in advanced two-dimensional barcode readers and sample tracking technologies that support laboratory automation and biobank automation systems.
Major companies operating in the biobank automation systems market are Thermo Fisher Scientific Inc., Azenta Life Sciences, Sartorius AG, Becton Dickinson and Company, Tecan Group Ltd., Hamilton Company, Eppendorf SE, PHC Holdings Corporation, Haier Biomedical Co. Ltd., ASKION GmbH, LiCONiC AG, Micronic Holding B.V., Revvity Inc., Qiagen N.V., Greiner Bio-One International GmbH, BioLife Solutions Inc., LVL Technologies GmbH & Co. KG, RTS Life Science Ltd., Brooks Automation Inc., SP Scientific.
North America was the largest region in the biobank automation systems market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biobank automation systems market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the biobank automation systems market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the biobank automation systems market by increasing costs of robotic systems, automated storage units, and control electronics. These impacts are strongest in Asia-Pacific-manufactured systems deployed in North America and Europe. While tariffs have raised capital investment costs, they have also encouraged local manufacturing, system modularization, and innovation in cost-efficient automation platforms.
The biobank automation systems market research report is one of a series of new reports that provides biobank automation systems market statistics, including biobank automation systems industry global market size, regional shares, competitors with a biobank automation systems market share, detailed biobank automation systems market segments, market trends and opportunities, and any further data you may need to thrive in the biobank automation systems industry. This biobank automation systems market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Biobank automation systems refer to advanced automated technologies, robotics, and digital tools developed to streamline the collection, processing, tracking, storage, and retrieval of biological samples with superior accuracy, efficiency, and security. These systems reduce manual involvement, limit errors, improve sample traceability, and enable large-scale biorepository operations through integrated software, automated storage, and high-throughput workflows.
The primary product categories that make up biobank automation systems include automated storage systems, automated sample preparation systems, automated liquid handling systems, and others. Automated storage systems refer to highly engineered, temperature-controlled robotic platforms designed to store, preserve, track, and retrieve biological samples with precision and minimal manual interaction, ensuring consistent sample integrity across extensive collections. These systems are applied in key areas such as drug discovery, regenerative medicine, biobanking, and others, and are utilized by pharmaceutical and biotechnology companies, academic and research institutions, hospitals, and other organizations.
The biobank automation systems market consists of revenues earned by entities by providing services such as system installation and validation, biobank workflow design and optimization, integration with laboratory information management systems (LIMS), preventive maintenance and equipment calibration, and training and technical support for automated biobanking operations. The market value includes the value of related goods sold by the service provider or included within the service offering. The biobank automation systems market also includes sales of automated sample storage systems, robotic liquid-handling platforms, automated tube and plate handling systems, barcode labeling and tracking solutions, and biobank sample management software. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The biobank automation systems market size is expected to see strong growth in the next few years. It will grow to $3.19 billion in 2030 at a compound annual growth rate (CAGR) of 9.4%. The growth in the forecast period can be attributed to precision medicine expansion, ai-driven sample management, global biobank collaborations, regulatory compliance requirements, demand for scalable storage solutions. Major trends in the forecast period include automated sample storage, robotic sample handling, high-throughput biobanking, digital sample traceability, integrated biobank software systems.
The rising prevalence of chronic diseases is expected to propel the growth of the biobank automation systems market moving forward. Chronic diseases, such as diabetes, cardiovascular diseases, cancer, and chronic respiratory disorders, are long-lasting conditions that generally progress slowly and require ongoing medical management. The increasing incidence of chronic diseases is largely attributed to population aging, with a growing number of people living into older age groups where conditions like cardiovascular disease, diabetes, and cancer are more common. Biobank automation systems help manage the growing burden of chronic diseases by enabling the reliable, large-scale storage and rapid retrieval of patient biospecimens for research, biomarker discovery, and the development of targeted therapies. For example, in February 2024, the World Health Organization (WHO) projected that global cancer incidence would exceed 35 million new cases by 2050, a 77% increase over the 20 million new cases reported in 2022. As a result, the rising prevalence of chronic diseases is driving the biobank automation systems market.
Leading companies in the biobank automation systems market are focusing on advanced innovations, such as eco-friendly cooling systems, to improve energy efficiency, reduce carbon footprints, and optimize large-scale sample storage. Eco-friendly cooling systems utilize advanced refrigeration technologies that use natural air or non-ozone-depleting refrigerants to minimize energy consumption, lower environmental impact, and support sustainable ultracold storage operations. For example, in February 2024, Azenta, Inc., a US-based life sciences company, launched the BioArc Ultra, a groundbreaking automated solution for high-density and eco-friendly ultracold sample management. BioArc Ultra enables automated, high-density ultracold sample storage and retrieval, helping biobanks maximize freezer capacity while maintaining sample integrity. The system also supports more sustainable biobanking operations through its energy-efficient design and eco-friendly refrigerants, reducing the environmental footprint of large-scale sample management. It is designed to streamline complex biorepository workflows, minimize manual handling risks, and offer secure, traceable management of critical biological samples for research and clinical applications.
In February 2023, Azenta Inc., a US-based life sciences company specializing in automated sample management and cold-chain solutions, acquired Ziath Ltd for an undisclosed amount. Through this acquisition, Azenta aims to strengthen its end-to-end sample lifecycle solutions by integrating advanced two-dimensional barcode scanning technologies that enhance accuracy, traceability, and high-throughput automation across sample registration, storage, and processing workflows for global life sciences clients. Ziath Ltd is a UK-based company specializing in advanced two-dimensional barcode readers and sample tracking technologies that support laboratory automation and biobank automation systems.
Major companies operating in the biobank automation systems market are Thermo Fisher Scientific Inc., Azenta Life Sciences, Sartorius AG, Becton Dickinson and Company, Tecan Group Ltd., Hamilton Company, Eppendorf SE, PHC Holdings Corporation, Haier Biomedical Co. Ltd., ASKION GmbH, LiCONiC AG, Micronic Holding B.V., Revvity Inc., Qiagen N.V., Greiner Bio-One International GmbH, BioLife Solutions Inc., LVL Technologies GmbH & Co. KG, RTS Life Science Ltd., Brooks Automation Inc., SP Scientific.
North America was the largest region in the biobank automation systems market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biobank automation systems market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the biobank automation systems market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the biobank automation systems market by increasing costs of robotic systems, automated storage units, and control electronics. These impacts are strongest in Asia-Pacific-manufactured systems deployed in North America and Europe. While tariffs have raised capital investment costs, they have also encouraged local manufacturing, system modularization, and innovation in cost-efficient automation platforms.
The biobank automation systems market research report is one of a series of new reports that provides biobank automation systems market statistics, including biobank automation systems industry global market size, regional shares, competitors with a biobank automation systems market share, detailed biobank automation systems market segments, market trends and opportunities, and any further data you may need to thrive in the biobank automation systems industry. This biobank automation systems market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Biobank automation systems refer to advanced automated technologies, robotics, and digital tools developed to streamline the collection, processing, tracking, storage, and retrieval of biological samples with superior accuracy, efficiency, and security. These systems reduce manual involvement, limit errors, improve sample traceability, and enable large-scale biorepository operations through integrated software, automated storage, and high-throughput workflows.
The primary product categories that make up biobank automation systems include automated storage systems, automated sample preparation systems, automated liquid handling systems, and others. Automated storage systems refer to highly engineered, temperature-controlled robotic platforms designed to store, preserve, track, and retrieve biological samples with precision and minimal manual interaction, ensuring consistent sample integrity across extensive collections. These systems are applied in key areas such as drug discovery, regenerative medicine, biobanking, and others, and are utilized by pharmaceutical and biotechnology companies, academic and research institutions, hospitals, and other organizations.
The biobank automation systems market consists of revenues earned by entities by providing services such as system installation and validation, biobank workflow design and optimization, integration with laboratory information management systems (LIMS), preventive maintenance and equipment calibration, and training and technical support for automated biobanking operations. The market value includes the value of related goods sold by the service provider or included within the service offering. The biobank automation systems market also includes sales of automated sample storage systems, robotic liquid-handling platforms, automated tube and plate handling systems, barcode labeling and tracking solutions, and biobank sample management software. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Biobank Automation Systems Market Characteristics
3. Biobank Automation Systems Market Supply Chain Analysis
4. Global Biobank Automation Systems Market Trends and Strategies
5. Biobank Automation Systems Market Analysis of End Use Industries
7. Global Biobank Automation Systems Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Biobank Automation Systems Total Addressable Market (TAM) Analysis for the Market
9. Biobank Automation Systems Market Segmentation
10. Biobank Automation Systems Market Regional and Country Analysis
11. Asia-Pacific Biobank Automation Systems Market
12. China Biobank Automation Systems Market
13. India Biobank Automation Systems Market
14. Japan Biobank Automation Systems Market
15. Australia Biobank Automation Systems Market
16. Indonesia Biobank Automation Systems Market
17. South Korea Biobank Automation Systems Market
18. Taiwan Biobank Automation Systems Market
19. South East Asia Biobank Automation Systems Market
20. Western Europe Biobank Automation Systems Market
21. UK Biobank Automation Systems Market
22. Germany Biobank Automation Systems Market
23. France Biobank Automation Systems Market
24. Italy Biobank Automation Systems Market
25. Spain Biobank Automation Systems Market
26. Eastern Europe Biobank Automation Systems Market
27. Russia Biobank Automation Systems Market
28. North America Biobank Automation Systems Market
29. USA Biobank Automation Systems Market
30. Canada Biobank Automation Systems Market
31. South America Biobank Automation Systems Market
32. Brazil Biobank Automation Systems Market
33. Middle East Biobank Automation Systems Market
34. Africa Biobank Automation Systems Market
36. Biobank Automation Systems Market Competitive Landscape and Company Profiles
37. Biobank Automation Systems Market Other Major and Innovative Companies
40. Biobank Automation Systems Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Biobank Automation Systems Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses biobank automation systems market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for biobank automation systems? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The biobank automation systems market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product Type: Automated Storage Systems; Automated Sample Preparation Systems; Automated Liquid Handling Systems; Other Product Types2) By Application: Drug Discovery; Regenerative Medicine; Biobanking; Other Applications
3) By End-User: Pharmaceutical And Biotechnology Companies; Academic And Research Institutes; Hospitals; Other End-Users
Subsegments:
1) By Automated Storage Systems: Automated Ultra Low Temperature Freezer Systems; Automated Cryogenic Storage Systems; Automated High Density Biobanking Storage Systems; Automated Room Temperature Sample Storage Systems; Automated Tube And Vial Storage Systems2) By Automated Sample Preparation Systems: Automated Nucleic Acid Extraction Systems; Automated Cell Preparation Systems; Automated Protein Purification Systems; Automated Histology And Tissue Processing Systems; Automated Sample Aliquoting Systems
3) By Automated Liquid Handling Systems: Automated Pipetting Workstation Systems; Automated Microplate Handling Systems; Automated Reagent Dispensing Systems; Automated Serial Dilution Systems; Automated Microplate Washing Systems
4) By Other Product Types: Automated Tube Decapping And Capping Systems; Barcode Labeling And Scanning Systems; Laboratory Information Management System Integration Modules; Environmental Monitoring And Control Systems; Robotic Laboratory Integration Platforms
Companies Mentioned: Thermo Fisher Scientific Inc.; Azenta Life Sciences; Sartorius AG; Becton Dickinson and Company; Tecan Group Ltd.; Hamilton Company; Eppendorf SE; PHC Holdings Corporation; Haier Biomedical Co. Ltd.; ASKION GmbH; LiCONiC AG; Micronic Holding B.V.; Revvity Inc.; Qiagen N.V.; Greiner Bio-One International GmbH; BioLife Solutions Inc.; LVL Technologies GmbH & Co. KG; RTS Life Science Ltd.; Brooks Automation Inc.; SP Scientific
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Biobank Automation Systems market report include:- Thermo Fisher Scientific Inc.
- Azenta Life Sciences
- Sartorius AG
- Becton Dickinson and Company
- Tecan Group Ltd.
- Hamilton Company
- Eppendorf SE
- PHC Holdings Corporation
- Haier Biomedical Co. Ltd.
- ASKION GmbH
- LiCONiC AG
- Micronic Holding B.V.
- Revvity Inc.
- Qiagen N.V.
- Greiner Bio-One International GmbH
- BioLife Solutions Inc.
- LVL Technologies GmbH & Co. KG
- RTS Life Science Ltd.
- Brooks Automation Inc.
- SP Scientific
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 2.22 Billion |
| Forecasted Market Value ( USD | $ 3.19 Billion |
| Compound Annual Growth Rate | 9.4% |
| Regions Covered | Global |
| No. of Companies Mentioned | 21 |
